Dysfunction of CCR1<SUP>+</SUP> decidual macrophages is a potential risk factor in the occurrence of unexplained recurrent pregnancy loss

Yifei Sang,Yanhong Li,Ling Xu,Jiajia Chen,Dajin Li,Meirong Du
DOI: https://doi.org/10.3389/fimmu.2022.1045532
IF: 7.3
2022-01-01
Frontiers in Immunology
Abstract:Recurrent pregnancy loss (RPL) puzzles 1-3% of women of childbearing age worldwide. Immunological factors account for more than 60% of cases of unexplained RPL (URPL); however, the underlying mechanism remains unclear. Here, using single-cell sequencing data and functional experiments with clinical samples, we identified a distinct population of CCR1(+) decidual macrophages (dM phi) that were preferentially enriched in the decidua from normal early pregnancies but were substantially decreased in patients with URPL. Specific gene signatures endowed CCR1(+) dM phi with immunosuppressive and migration-regulatory properties, which were attenuated in URPL. Additionally, CCR1(+) dM phi promoted epithelial-to-mesenchymal transition (EMT) to promote trophoblast migration and invasion by activating the ERK1/2 signaling pathway. Decidual stromal cell (DSC)-derived CCL8 was the key regulator of CCR1(+) dM phi as CCL8 recruited peripheral CCR1(+) monocytes, induced a CCR1(+) dM phi-like phenotype, and reinforced the CCR1(+) dM phi-exerted modulation of trophoblasts. In patients with URPL, CCL8 expression in DSCs was decreased and trophoblast EMT was defective. Our findings revealed that CCR1(+) dM phi play an important role in immune tolerance and trophoblast functions at the maternal-fetal interface. Additionally, decreased quantity and dysregulated function of CCR1(+) dM phi result in URPL. In conclusion, we provide insights into the crosstalk between CCR1(+) dM phi, trophoblasts, and DSCs at the maternal-fetal interface and macrophage-targeted interventions of URPL.
What problem does this paper attempt to address?